Related content

Flucytosine dose requirements in a patient receiving continuous veno-venous haemofiltration

By Thomson A.H.   Shankland G.   Clareburt C.   Binning S.  

Intensive Care Medicine, Vol. 28, Iss. 7, 2002-07 ,pp. : 999-999

Springer Publishing Company

Access to resources Recommend Favorite

Pre-Dilution vs. Post-Dilution during Continuous Veno-Venous Hemofiltration: Impact on Filter Life and Azotemic Control

By  

Nephron Clin Pract, Vol. 94, Iss. 4, 2004-11 ,pp. : c94-c98

Karger

Access to resources Recommend Favorite

Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration

By Hansen Ernil   Bucher Michael   Jakob Wolfgang   Lemberger Peter   Kees Frieder  

Intensive Care Medicine, Vol. 27, Iss. 2, 2001-02 ,pp. : 371-375

Springer Publishing Company

Access to resources Recommend Favorite

A pilot randomised controlled comparison of continuous veno–venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid–base balance

By Baldwin Ian   Naka Toshio   Koch Bill   Fealy Nigel   Bellomo Rinaldo  

Intensive Care Medicine, Vol. 33, Iss. 5, 2007-05 ,pp. : 830-835

Springer Publishing Company

Access to resources Recommend Favorite

Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study

By Joannidis Michael   Kountchev Jordan   Rauchenzauner Markus   Schusterschitz Nicola   Ulmer Hanno   Mayr Andreas   Bellmann Romuald  

Intensive Care Medicine, Vol. 33, Iss. 9, 2007-09 ,pp. : 1571-1579

Springer Publishing Company

Access to resources Recommend Favorite